{"name": "Galenea", "permalink": "galenea", "crunchbase_url": "http://www.crunchbase.com/company/galenea", "homepage_url": "http://www.galenea.com/", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@Galenea.com", "phone_number": "(617) 374-1010", "description": "", "created_at": "Thu Jul 28 03:32:12 UTC 2011", "updated_at": "Thu Jul 28 03:32:11 UTC 2011", "overview": "\u003Cp\u003EGalenea Corp., a biopharmaceutical company, engages in developing therapeutics for central nervous system (CNS) diseases. The company focuses on psychiatric disorders, schizophrenia and calcineurin, and obesity and 5-HT2C agonists. Its products include in vitro and in vivo synaptic functional screening and brain slice electrophysiology assays, which include techniques for recording disease-relevant neuronal activity in the prefrontal cortex to measure the effects of drug candidates in animals performing critical memory or cognition-dependent tasks. The company was founded in 2003 and is based in Cambridge, Massachusetts.\u003C/p\u003E", "image":  {"available_sizes":    [[[150,       22],      "assets/images/resized/0014/6615/146615v1-max-150x150.png"],     [[250,       37],      "assets/images/resized/0014/6615/146615v1-max-250x250.png"],     [[321,       48],      "assets/images/resized/0014/6615/146615v1-max-450x450.png"]],   "attribution": null}, "products":  [], "relationships":  [{"is_past": false,    "title": "President \u0026 CEO",    "person":     {"first_name": "Mark",      "last_name": "B. Benjamin",      "permalink": "mark-b-benjamin"}},   {"is_past": false,    "title": "CFO",    "person":     {"first_name": "David",      "last_name": "Neafus",      "permalink": "david-neafus"}}], "competitions":  [], "providerships":  [], "total_money_raised": "$4.5M", "funding_rounds":  [{"round_code": "grant",    "source_url": "http://www.galenea.com/story.php?id=10",    "source_description": "Galenea Awarded $4.5 Million Grant for Advancement of Innovative Synaptic Transmission Screen",    "raised_amount": 4500000.0,    "raised_currency_code": "USD",    "funded_year": 2010,    "funded_month": 10,    "funded_day": 14,    "investments":     []}], "investments":  [], "acquisition": null, "acquisitions":  [], "offices":  [{"description": "",    "address1": "300 Technology Square",    "address2": "2nd Floor ",    "zip_code": "02139",    "city": "Cambridge",    "state_code": "MA",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}